» Articles » PMID: 20634584

Familial Alzheimer's Disease Mutations in Presenilins: Effects on Endoplasmic Reticulum Calcium Homeostasis and Correlation with Clinical Phenotypes

Overview
Publisher Sage Publications
Specialties Geriatrics
Neurology
Date 2010 Jul 17
PMID 20634584
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in presenilins 1 and 2 (PS1 and PS2) are responsible for approximately 40% of all early onset familial Alzheimer's disease (FAD) monogenic cases. Presenilins (PSs) function as the catalytic subunit of γ-secretase and support cleavage of the amyloid-β protein precursor (AβPP). We previously discovered that PSs also function as passive endoplasmic reticulum (ER) calcium (Ca2+) leak channels and that most FAD mutations in PSs affected their ER Ca2+ leak function. To further validate the relevance of our findings to human disease, we here performed Ca2+ imaging experiments with lymphoblasts established from FAD patients. We discovered that most FAD mutations in PSs disrupted ER Ca2+ leak function and resulted in increased ER Ca2+ pool in human lymphoblasts. However, we found that a subset of PS1 FAD mutants supported ER Ca2+ leak activity, as ER Ca2+ pool was unaffected in lymphoblasts. Most of the "functional" mutations for ER Ca2+ leak were clustered in the exon 8-9 area of PSEN1 gene and segregated with the cotton wool plaques and spastic paraparesis clinical phenotype occasionally observed in PS1 FAD patients. Our findings with the "functional" and "non-functional" PS1 FAD mutants were confirmed in Ca2+ rescue experiments with PS double-knockout mouse embryonic fibroblasts. Based on the combined effects of the PS1 FAD mutations on ER Ca2+ leak and γ-secretase activities we propose a model that explains the heterogeneity observed in FAD. The proposed model has implications for understanding the pathogenesis of both familial and sporadic AD.

Citing Articles

The etiology and prevention of early-stage tau pathology in higher cortical circuits: Insights from aging rhesus macaques.

Datta D, Arnsten A Alzheimers Dement. 2025; 21(2):e14477.

PMID: 39776253 PMC: 11848412. DOI: 10.1002/alz.14477.


Neuronal γ-secretase regulates lipid metabolism, linking cholesterol to synaptic dysfunction in Alzheimer's disease.

Essayan-Perez S, Sudhof T Neuron. 2023; 111(20):3176-3194.e7.

PMID: 37543038 PMC: 10592349. DOI: 10.1016/j.neuron.2023.07.005.


Mechanistic contribution of CaV3.2 calcium channels to trigeminal neuralgia pathophysiology not clarified.

Liedtke W F1000Res. 2022; 11:718.

PMID: 36128556 PMC: 9468618. DOI: 10.12688/f1000research.122997.2.


Structure and dynamics of γ-secretase with presenilin 2 compared to presenilin 1.

Dehury B, Tang N, Blundell T, Kepp K RSC Adv. 2022; 9(36):20901-20916.

PMID: 35515530 PMC: 9065803. DOI: 10.1039/c9ra02623a.


Aberrant miR-339-5p/neuronatin signaling causes prodromal neuronal calcium dyshomeostasis in mutant presenilin mice.

Zou H, Guo L, Zhang B, Chen S, Wu X, Liu X J Clin Invest. 2022; 132(8).

PMID: 35426376 PMC: 9012292. DOI: 10.1172/JCI149160.


References
1.
Yagi T, Giallourakis C, Mohanty S, Scheidig C, Shen J, Zheng H . Defective signal transduction in B lymphocytes lacking presenilin proteins. Proc Natl Acad Sci U S A. 2008; 105(3):979-84. PMC: 2242696. DOI: 10.1073/pnas.0707755105. View

2.
Ataka S, Tomiyama T, Takuma H, Yamashita T, Shimada H, Tsutada T . A novel presenilin-1 mutation (Leu85Pro) in early-onset Alzheimer disease with spastic paraparesis. Arch Neurol. 2004; 61(11):1773-6. DOI: 10.1001/archneur.61.11.1773. View

3.
Hardy J, Selkoe D . The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002; 297(5580):353-6. DOI: 10.1126/science.1072994. View

4.
Borden L, Maxfield F, Goldman J, Shelanski M . Resting [Ca2+]i and [Ca2+]i transients are similar in fibroblasts from normal and Alzheimer's donors. Neurobiol Aging. 1992; 13(1):33-8. DOI: 10.1016/0197-4580(92)90005-i. View

5.
Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H . A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998; 4(4):452-5. DOI: 10.1038/nm0498-452. View